From: Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box
QA scheme | Scope | Website |
---|---|---|
ASCO/CAP | To improve the accuracy of test results and ensure that patients receive appropriate care | |
UK NEQAS | To promote optimal patient care by facilitating the availability of reliable laboratory investigations, through provision of objective information on participant performance and professional advice and assistance where appropriate | |
NordiQC | To promote the quality of IHC by arranging schemes for pathology laboratories, assessing tissue stains, giving recommendations for improvement and providing good protocols | |
Canadian external quality assurance program | To systematically monitor and improve the proficiency of IHC testing laboratories and those involved with IHC testing nationwide | |
The RCPA Quality Assurance Program | To provide external proficiency testing for histopathology laboratories in the areas of diagnostic and technical expertise |